Human Genome Sciences

Glaxosmithkline Plc Completes Acquisition Of Human Genome Sciences
Reuters
Fri, 06/6/14 - 10:09 am
GSK
M&A
Human Genome Sciences
10 top drug launch disasters
Fierce Pharma
Wed, 11/28/12 - 11:13 am
drug launches
Rare Disease Therapeutics
Anascorp
AstraZeneca
Brilinta
Somaxon
Silenor
Sanofi
Multaq
Savient
Krystexxa
XenoPort
Horizant
Human Genome Sciences
Benlysta
Zaltrap
Dendreon
Provenge
KV Pharmaceutical
Makena
AstraZeneca In Strong Position With Brilinta
Seeking Alpha
Mon, 08/27/12 - 10:21 am
Brilinta
AstraZeneca
Bristol-Myers Squibb
GSK
Sanofi
Human Genome Sciences
Medicines Company
GlaxoSmithKline: Don't Pass On This Long-Term Gem
Seeking Alpha
Tue, 08/14/12 - 10:59 am
GSK
Abbott Laboratories
Pfizer
Merck
JNJ
Human Genome Sciences
9 Rallying Healthcare Stocks Seeing Strong Sales Trends
Seeking Alpha
Sat, 08/4/12 - 11:32 am
Cynosure
Human Genome Sciences
Alexion
Watson
The Medicines Company
Gilead Sciences
Medtox
Trinity Biotech
GSK completes $3 billion acquisition of Human Genome
Reuters
Fri, 08/3/12 - 11:23 am
GSK
Human Genome Sciences
M&A
Loss at HGSI Wider Than Expected
Yahoo/Zacks
Thu, 08/2/12 - 10:20 am
earnings
Human Genome Sciences
GlaxoSmithKline's R&D Is Delivering, But The Street's Not Buying
Seeking Alpha
Wed, 07/25/12 - 11:32 pm
R&D
GSK
Pfizer
Theravance
Human Genome Sciences
Gilead
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Dealtalk: Surge in biotech deals to unlock big investor profits
Reuters
Wed, 07/18/12 - 12:16 pm
M&A
GSK
Human Genome Sciences
Human Genome agrees to Glaxo's $3.6B bid
Marketwatch
Mon, 07/16/12 - 11:54 am
GSK
M&A
Human Genome Sciences
GSK in weekend talks to buy Human Genome: sources
Reuters
Sun, 07/15/12 - 11:37 am
GSK
Human Genome Sciences
M&A
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sun, 07/15/12 - 11:22 am
Alkermes
Medivation
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Questcor Pharmaceuticals
Arena Pharmaceuticals
Seattle Genetics
Incyte
United Therapeutics
Amarin
ONYX Pharmaceuticals
Pharmacyclics
Human Genome Sciences
Theravance
A Possible Bidding War For Human Genome Sciences, But Celgene Is The Real Gem
Seeking Alpha
Mon, 07/9/12 - 10:12 am
M&A
Human Genome Sciences
Celgene
Amylin
GSK
Novo Nordisk
Exclusive: Celgene mulls Human Genome Sciences bid - source
Reuters
Sat, 07/7/12 - 11:27 am
Celgene
Human Genome Sciences
M&A
6 Pharmaceutical Stocks To Consider Now
Seeking Alpha
Sat, 06/30/12 - 03:50 pm
GSK
Human Genome Sciences
Abbott Laboratories
JNJ
Pfizer
Merck
3 Things to Watch With Human Genome Sciences
Motley Fool
Sat, 06/30/12 - 03:27 pm
Human Genome Sciences
M&A
Benlysta
GSK again extends its $2.6 billion Human Genome offer
Reuters
Fri, 06/29/12 - 09:22 am
GSK
Human Genome Sciences
M&A
Hostile Takeovers And The Race To Reduce Residual Risk In Heart Disease Patients
Seeking Alpha
Wed, 06/20/12 - 12:38 pm
M&A
heart disease
Human Genome Sciences
Amylin
GSK
Eli Lilly
Merck
Novo Nordisk
Pfizer
Showdown Looms Between Glaxo and Human Genome Sciences
WSJ Online
Tue, 06/19/12 - 12:14 pm
GSK
Human Genome Sciences
M&A

Pages